Development of immunoglobulin λ-chain-positive B cells, but not editing of immunoglobulin κ-chain, depends on NF-κB signals

Nature Immunology

Volumn 10, Issue 6, 2009, Pages 647-654

  Derudder, Emmanuel ^a   Cadera, Emily J ^b   Vahl, J Christoph ^a,c   Wang, Jing ^a   Fox, Casey J ^d   Zha, Shan ^e   van Loo, Geert ^f   Pasparakis, Manolis ^g   Schlissel, Mark S ^b   Schmidt Supprian, Marc ^a,c   Rajewsky, Klaus ^a  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d JACKSON LABORATORY   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f GHENT UNIVERSITY   (Belgium)

^g UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; PROTEIN BCL 2;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; GENE LOCUS; GENE REARRANGEMENT; MOUSE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; I-KAPPA B KINASE; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 67349211157     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1732     Document Type: Article

References (50)

1. Siebenlist, U., Brown, K. & Claudio, E. Control of lymphocyte development by nuclear factor-κB. Nat. Rev. Immunol. 5, 435-445 (2005).
2. Gerondakis, S. et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene 25, 6781-6799 (2006).
3. Mackay, F., Silveira, P.A. & Brink, R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr. Opin. Immunol. 19, 327-336 (2007).
4. Pasparakis, M., Schmidt-Supprian, M. & Rajewsky, K. IκB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196, 743-752 (2002).
5. Sasaki, Y. et al. Canonical NF-κB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729-739 (2006).
6. Luedde, T. et al. IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc. Natl. Acad. Sci. USA 105, 9733-9738 (2008).
7. Feng, B., Cheng, S., Pear, W.S. & Liou, H.C. NF-κB inhibitor blocks B cell development at two checkpoints. Med. Immunol. 3, 1 (2004).
8. + pre-B cells to small, CD43- pre-B cells. Int. Immunol. 17, 815-825 (2005).
9. Verkoczy, L. et al. A role for nuclear factor κB/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22, 519-531 (2005).
10. Nemazee, D. Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6, 728-740 (2006).
11. Bredemeyer, A.L. et al. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 456, 819-823 (2008).
12. Hobeika, E. et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 103, 13789-13794 (2006).
13. Ait-Azzouzene, D. et al. An immunoglobulin C κ-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system. J. Exp. Med. 201, 817-828 (2005).
14. Takeda, S. et al. Deletion of the immunoglobulin κ chain intron enhancer abolishes κ chain gene rearrangement in cis but not λ chain gene rearrangement in trans. EMBO J. 12, 2329-2336 (1993).
15. Strasser, A. et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88, 8661-8665 (1991).
16. Schmidt-Supprian, M. & Rajewsky, K. Vagaries of conditional gene targeting. Nat. Immunol. 8, 665-668 (2007).
17. Allman, D. et al. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167, 6834-6840 (2001).
18. Debnath, I., Roundy, K.M., Weis, J.J. & Weis, J.H. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes. J. Immunol. 178, 7139-7150 (2007).
19. Lindsley, R.C., Thomas, M., Srivastava, B. & Allman, D. Generation of peripheral B cells occurs via two spatially and temporally distinct pathways. Blood 109, 2521-2528 (2007).
20. Radic, M.Z., Erikson, J., Litwin, S. & Weigert, M. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177, 1165-1173 (1993).
21. Constantinescu, A. & Schlissel, M.S. Changes in locus-specific V(D)J recombinase activity induced by immunoglobulin gene products during B cell development. J. Exp. Med. 185, 609-620 (1997).
22. Arakawa, H., Shimizu, T. & Takeda, S. Re-evaluation of the probabilities for productive arrangements on the κ and λ loci. Int. Immunol. 8, 91-99 (1996).
23. Lang, J. et al. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 186, 1513-1522 (1997).
24. Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506-1510 (1995).
25. White, E. The pims and outs of survival signaling: Role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev. 17, 1813-1816 (2003).
26. Enzler, T. et al. Alternative and classical NF-κ B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 25, 403-415 (2006).
27. Grandien, A., Bras, A. & Martinez, C. Acquisition of CD40 expression during murine B-cell differentiation. Scand. J. Immunol. 43, 47-55 (1996).
28. Applequist, S.E., Wallin, R.P. & Ljunggren, H.G. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int. Immunol. 14, 1065-1074 (2002).
29. Kawai, T. & Akira, S. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13, 460-469 (2007).
30. Inoue, J., Gohda, J. & Akiyama, T. Characteristics and biological functions of TRAF6. Adv. Exp. Med. Biol. 597, 72-79 (2007).
31. Mackay, F. & Schneider, P. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev. 19, 263-276 (2008).
32. Stadanlick, J.E. et al. Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling. Nat. Immunol. 9, 1379-1387 (2008).
33. Kistler, B. et al. Induction of nuclear factor-κB during primary B cell differentiation. J. Immunol. 160, 2308-2317 (1998).
34. Amin, R.H. & Schlissel, M.S. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9, 613-622 (2008).
35. Inlay, M.A., Tian, H., Lin, T. & Xu, Y. Important roles for E protein binding sites within the immunoglobulin κ chain intronic enhancer in activating Vκ Jκ rearrangement. J. Exp. Med. 200, 1205-1211 (2004).
36. Scherer, D.C. et al. Corepression of RelA and c-rel inhibits immunoglobulin κ gene transcription and rearrangement in precursor B lymphocytes. Immunity 5, 563-574 (1996).
37. Vela, J.L. et al. Rearrangement of mouse immunoglobulin κ deleting element recombining sequence promotes immune tolerance and λ B cell production. Immunity 28, 161-170 (2008).
38. Engel, H., Rolink, A. & Weiss, S. B cells are programmed to activate κ and λ for rearrangement at consecutive developmental stages. Eur. J. Immunol. 29, 2167-2176 (1999).
39. Bendall, H.H., Sikes, M.L. & Oltz, E.M. Transcription factor NF-κ B regulates Ig λ light chain gene rearrangement. J. Immunol. 167 264-269 (2001).
40. Kawai, T. et al. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122 (1999).
41. Schmidt-Supprian, M. et al. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell 5, 981-992 (2000).
42. Ruland, J. et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kB and neural tube closure. Cell 104, 33-42 (2001).
43. von Bulow, G.U., van Deursen, J.M. & Bram, R.J. Regulation of the T-independent humoral response by TACI. Immunity 14, 573-582 (2001).
44. Pasparakis, M. et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417, 861-866 (2002).
45. Fox, C.J., Hammerman, P.S. & Thompson, C.B. The Pim kinases control rapamycin-resistant T cell survival and activation. J. Exp. Med. 201, 259-266 (2005).
46. Gareus, R. et al. Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat. Cell Biol. 9, 461-469 (2007).
47. Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235-249 (2008).
48. Zha, S. et al. Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proc. Natl. Acad. Sci. USA 105, 9302-9306 (2008).
49. Kawabe, T. et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178 (1994).
50. Seagal, J., Edry, E., Naftali, H. & Melamed, D. Generation and selection of an IgG-driven autoimmune repertoire during B-lymphopoiesis in Igmicro-deficient/lpr mice. Int. Immunol. 16, 905-913 (2004).